Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AVPR1A | P37288 | 1/20 | 0.55 |
| ▸ | MEN1 | O00255 | 4/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.51 |
| ▸ | LMNA | P02545 | 1/20 | 0.51 |
| ▸ | TGM2 | P21980 | 2/20 | 0.51 |
| ▸ | GAA | P10253 | 1/20 | 0.48 |
| ▸ | USP2 | O75604 | 1/20 | 0.48 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
| ▸ | HTT | P42858 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9011209 | 0.88 | AVPR1A (0.57) | AVPR1AMEN1KMT2AALDH1A1LMNA | |
| SCHEMBL7811811 | 0.83 | ALDH1A1 (0.53) | AVPR1AMEN1KMT2AALDH1A1LMNA | |
| SCHEMBL7813987 | 0.81 | ALDH1A1 (0.55) | AVPR1AMEN1KMT2AALDH1A1LMNA | |
| SCHEMBL9010991 | 0.80 | NPC1 (0.62) | MEN1KMT2AALDH1A1LMNAGAA | |
| SCHEMBL9011215 | 0.80 | AVPR1A (0.53) | AVPR1AMEN1KMT2AALDH1A1LMNA | |
| SCHEMBL4453090 | 0.78 | ALDH1A1 (0.77) | AVPR1AMEN1KMT2AALDH1A1LMNA | |
| SCHEMBL8522108 | 0.78 | FNTA (0.49) | AVPR1AMEN1KMT2AALDH1A1LMNA | |
| SCHEMBL9011033 | 0.77 | AVPR1A (0.55) | AVPR1AMEN1KMT2AALDH1A1LMNA | |
| SCHEMBL23013629 | 0.75 | LMNA (0.53) | ALDH1A1LMNAGAA | |
| SCHEMBL3582934 | 0.75 | ALDH1A1 (0.68) | AVPR1AMEN1KMT2AALDH1A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-1035178-C | Arylamide derivatives | SS PHARMACEUTICAL CO (JP) | 1997-06-18 | — | — | CN | disclosed |
| US-5532371-A | SIDE EFFECT REDUCTION | SS PHARMACEUTICAL CO., LTD. (JP) | 1996-07-02 | — | — | US | disclosed |
| US-5411972-A | Arylamide derivatives for treating hyperlipemia | SS PHARMACEUTICAL CO., LTD. (JP) | 1995-05-02 | — | — | US | disclosed |
| EP-0607536-A1 | Arylamide derivatives | SS PHARMACEUTICAL CO., LTD. (JP) | 1994-07-27 | — | — | EP | disclosed |